home / stock / bnox / bnox quote
Last: | $0.6818 |
---|---|
Change Percent: | -0.59% |
Open: | $0.67 |
Close: | $0.6818 |
High: | $0.735 |
Low: | $0.67 |
Volume: | 75,880 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.6818 | $0.67 | $0.6818 | $0.735 | $0.67 | 75,880 | 07-05-2024 |
$0.6661 | $0.729 | $0.6661 | $0.73 | $0.65 | 50,035 | 07-04-2024 |
$0.6661 | $0.729 | $0.6661 | $0.73 | $0.65 | 50,035 | 07-03-2024 |
$0.7075 | $0.7126 | $0.7075 | $0.73 | $0.6952 | 60,051 | 07-02-2024 |
$0.69 | $0.7332 | $0.69 | $0.7661 | $0.69 | 96,858 | 07-01-2024 |
$0.767 | $0.73 | $0.767 | $0.767 | $0.7 | 58,648 | 06-28-2024 |
$0.741 | $0.751 | $0.741 | $0.775 | $0.7401 | 34,234 | 06-27-2024 |
$0.747899 | $0.727 | $0.747899 | $0.77 | $0.664 | 70,538 | 06-26-2024 |
$0.716 | $0.7451 | $0.716 | $0.7875 | $0.715 | 59,873 | 06-25-2024 |
$0.7777 | $0.77 | $0.7777 | $0.81 | $0.72 | 146,193 | 06-24-2024 |
$0.7706 | $0.7675 | $0.7706 | $0.785 | $0.74 | 39,387 | 06-21-2024 |
$0.768 | $0.771 | $0.768 | $0.8 | $0.7505 | 72,494 | 06-20-2024 |
$0.803 | $0.87 | $0.803 | $0.87 | $0.751 | 181,679 | 06-19-2024 |
$0.803 | $0.87 | $0.803 | $0.87 | $0.751 | 181,679 | 06-18-2024 |
$0.792826 | $0.8 | $0.792826 | $0.830261 | $0.7401 | 165,476 | 06-17-2024 |
$0.78 | $0.809 | $0.78 | $0.8299 | $0.76 | 176,048 | 06-14-2024 |
$0.8254 | $0.814 | $0.8254 | $0.85 | $0.7201 | 1,358,727 | 06-13-2024 |
$0.6988 | $0.7105 | $0.6988 | $0.7282 | $0.65 | 174,189 | 06-12-2024 |
$0.6874 | $0.6857 | $0.6874 | $0.72 | $0.6776 | 98,110 | 06-11-2024 |
$0.7069 | $0.7097 | $0.7069 | $0.76 | $0.6782 | 132,270 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
ADELAIDE, Australia and CAMBRIDGE, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (“Bionomics” or the “Company”), a clinical-stage biotechnology company developing novel, potential first-in-class, allosteric ion channel modulators to treat pat...
ADELAIDE, Australia and CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nerv...
2024-03-21 07:55:00 ET DENVER, Colo., Mar 21, 2024 ( 247marketnews.com )- Bionomics Limited (NASDAQ: BNOX ) released, this morning, the full dataset analysis from its Phase 2b ATTUNE trial in patients with post-traumatic stress disorder. The full data analysis shows that ATTUNE ...